IPO Price History
Closed
Zenith Drugs Limited logo

Zenith Drugs Limited IPO

SME IPOListedZENITHDRUGNSE
Current Market Price (CMP)
₹78.45(-0.70%)
Current Price (CMP)
₹78.45(-0.70%)

Live Market Quote

Listing Price & Gain
₹110(+39.24%)

Day 1 Exchange Open

IPO Issue Price
₹79

Band: ₹75 - ₹79

Total Subscription
104.84x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
19 Feb 2024
IPO Bidding Closes
22 Feb 2024
Allotment & Refunds
Completed
Exchange Listing Day
27 Feb 2024

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 104.84x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)0x
Non-Institutional Investors (NII / HNI)0x
Retail Individual Investors (RII)0x
Total Subscription104.84x
Updated as on 22-Feb-2024 17:42:00

Listing Day & Return Performance

Listing Day Gain+39.24%
₹79 (Issue) → ₹110 (List)
Per share profit: +₹31.00
Holding Return (Till Date)-0.70%
₹79 (Issue) → ₹78.45 (CMP)
Net gain per share: ₹-0.55
Post-Listing Performance (Listing Day → Today):-28.68%

About Zenith Drugs Limited IPO

Zenith Drugs Limited is an Indian public offering categorized under the SME (Small and Medium Enterprise) segment. The public issue opened for bidding on 19 Feb 2024 and concluded on 22 Feb 2024, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹75 - ₹79.

During the bidding window, Zenith Drugs Limited witnessed heavy demand with an overall subscription of 104.84 times. Institutional investors (QIB) subscribed —, non-institutional high-net-worth investors (NII) subscribed —, and retail individual investors (RII) bid — their reserved quota.

The equity shares of Zenith Drugs Limited officially debuted on the stock exchanges on 27 Feb 2024 at an opening listing price of ₹110, delivering a listing day return of +39.24% (premium) over the final issue price. As per the latest market data, the stock trades at ₹78.45, representing an overall decline of -0.70% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Zenith Drugs Limited IPO?
The issue price of Zenith Drugs Limited IPO was fixed at ₹79 per equity share. The indicative bidding price band was ₹75 - ₹79.
What were the open, close, and listing dates for Zenith Drugs Limited IPO?
Zenith Drugs Limited IPO opened on 19 Feb 2024, closed on 22 Feb 2024, listed on 27 Feb 2024.
How much was Zenith Drugs Limited IPO subscribed?
The IPO received an overall subscription of 104.84 times. Category-wise, QIBs subscribed —x, NIIs subscribed —x, and Retail investors subscribed —x.
What was the listing price and listing gain of Zenith Drugs Limited IPO?
Zenith Drugs Limited IPO listed on the stock exchange at ₹110, delivering a listing gain of 39.24% compared to the IPO issue price of ₹79.
Is Zenith Drugs Limited IPO a Mainboard or SME IPO?
Zenith Drugs Limited IPO is a SME IPO listed on the SME platform of NSE.
What is the current return of Zenith Drugs Limited IPO since its IPO?
At the latest market quote of ₹78.45, Zenith Drugs Limited IPO has generated an all-time return of -0.70% since its initial public offering.

Related SME IPOs (2024)

NMSTEEL
NewMalayalam Steel Limited
₹900.00%
IDENTICAL
Identical Brains Studios Limited
₹54+75.93%
SFML
Supreme Facility Management Limited
₹76-1.32%
PURPLEUTED
Purple United Sales Limited
₹126+57.94%